Icad Inc Stock Current Valuation

ICAD Stock  USD 1.60  0.02  1.27%   
Valuation analysis of Icad Inc helps investors to measure Icad's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. The current year's Enterprise Value Multiple is expected to grow to -3.15. Fundamental drivers impacting Icad's valuation include:
Price Book
1.3375
Enterprise Value
23 M
Enterprise Value Ebitda
(1.89)
Price Sales
2.3968
Enterprise Value Revenue
0.9062
Undervalued
Today
1.60
Please note that Icad's price fluctuation is very risky at this time. Calculation of the real value of Icad Inc is based on 3 months time horizon. Increasing Icad's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Icad Inc is useful when determining the fair value of the Icad stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Icad. Since Icad is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Icad Stock. However, Icad's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  1.6 Real  2.38 Target  4.88 Hype  1.61 Naive  1.51
The real value of Icad Stock, also known as its intrinsic value, is the underlying worth of Icad Inc Company, which is reflected in its stock price. It is based on Icad's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Icad's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Icad's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
2.38
Real Value
7.50
Upside
Estimating the potential upside or downside of Icad Inc helps investors to forecast how Icad stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Icad more accurately as focusing exclusively on Icad's fundamentals will not take into account other important factors:
Earnings
Estimates (0)
LowProjectedHigh
-0.08-0.06-0.05
Details
Hype
Prediction
LowEstimatedHigh
0.081.616.73
Details
Naive
Forecast
LowNext ValueHigh
0.031.516.62
Details
3 Analysts
Consensus
LowTarget PriceHigh
4.444.885.42
Details

Icad Current Valuation Analysis

Icad's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
 2021 2022 2023 2024 (projected)
Total Operating Expenses35.0M33.7M22.2M20.0M
Cost Of Revenue9.4M8.1M2.8M2.6M

Enterprise Value

 = 

Market Cap + Debt

-

Cash

More About Current Valuation | All Equity Analysis

Current Icad Current Valuation

    
  22.98 M  
Most of Icad's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Icad Inc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Icad Current Valuation Driver Correlations

Understanding the fundamental principles of building solid financial models for Icad is extremely important. It helps to project a fair market value of Icad Stock properly, considering its historical fundamentals such as Current Valuation. Since Icad's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Icad's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Icad's interrelated accounts and indicators.
0.280.87-0.44-0.180.550.190.340.450.690.580.480.080.110.190.45-0.610.430.840.470.550.030.140.14-0.310.26-0.30.140.160.06
0.280.040.08-0.10.560.360.080.490.350.030.190.32-0.030.32-0.06-0.39-0.240.450.040.06-0.30.120.32-0.51-0.10.1-0.02-0.04-0.16
0.870.04-0.76-0.280.380.240.47-0.060.670.380.11-0.010.320.140.24-0.450.640.620.310.360.320.310.12-0.310.22-0.170.350.390.29
-0.440.08-0.760.56-0.35-0.5-0.680.48-0.70.260.470.04-0.25-0.22-0.060.16-0.7-0.160.260.26-0.36-0.680.150.52-0.27-0.25-0.76-0.79-0.69
-0.18-0.1-0.280.56-0.63-0.66-0.970.14-0.610.570.410.5-0.2-0.1-0.150.54-0.49-0.240.750.450.32-0.830.650.78-0.18-0.75-0.71-0.68-0.74
0.550.560.38-0.35-0.630.620.620.420.84-0.180.08-0.01-0.070.270.25-0.640.190.62-0.28-0.15-0.490.56-0.26-0.780.090.340.370.340.29
0.190.360.24-0.5-0.660.620.61-0.060.72-0.5-0.320.230.160.340.1-0.40.080.16-0.56-0.440.070.67-0.48-0.60.140.560.690.70.54
0.340.080.47-0.68-0.970.620.61-0.160.66-0.44-0.36-0.510.240.090.17-0.580.620.35-0.62-0.33-0.240.79-0.55-0.780.220.640.710.680.73
0.450.49-0.060.480.140.42-0.06-0.160.180.460.770.18-0.340.140.47-0.4-0.30.550.380.44-0.5-0.280.05-0.070.12-0.31-0.35-0.39-0.41
0.690.350.67-0.7-0.610.840.720.660.18-0.15-0.050.140.00.360.33-0.490.390.52-0.2-0.17-0.070.69-0.29-0.720.260.260.630.640.5
0.580.030.380.260.57-0.18-0.5-0.440.46-0.150.790.190.14-0.050.29-0.19-0.040.50.930.950.22-0.60.540.490.05-0.77-0.54-0.5-0.55
0.480.190.110.470.410.08-0.32-0.360.77-0.050.790.220.1-0.080.24-0.26-0.250.440.680.72-0.2-0.520.290.370.2-0.59-0.48-0.5-0.5
0.080.32-0.010.040.5-0.010.23-0.510.180.140.190.220.00.55-0.030.31-0.39-0.130.330.070.47-0.180.320.30.18-0.40.030.05-0.19
0.11-0.030.32-0.25-0.2-0.070.160.24-0.340.00.140.10.00.15-0.31-0.220.220.01-0.060.190.330.140.090.190.260.040.260.260.26
0.190.320.14-0.22-0.10.270.340.090.140.36-0.05-0.080.550.150.21-0.1-0.050.08-0.09-0.060.230.27-0.12-0.090.250.020.370.370.2
0.45-0.060.24-0.06-0.150.250.10.170.470.330.290.24-0.03-0.310.21-0.230.210.350.160.330.080.21-0.26-0.090.4-0.120.220.240.22
-0.61-0.39-0.450.160.54-0.64-0.4-0.58-0.4-0.49-0.19-0.260.31-0.22-0.1-0.23-0.07-0.850.05-0.330.36-0.170.30.480.21-0.22-0.03-0.030.03
0.43-0.240.64-0.7-0.490.190.080.62-0.30.39-0.04-0.25-0.390.22-0.050.21-0.070.19-0.09-0.040.120.55-0.01-0.390.520.070.520.540.68
0.840.450.62-0.16-0.240.620.160.350.550.520.50.44-0.130.010.080.35-0.850.190.350.58-0.270.010.1-0.43-0.13-0.2-0.13-0.12-0.19
0.470.040.310.260.75-0.28-0.56-0.620.38-0.20.930.680.33-0.06-0.090.160.05-0.090.350.830.29-0.660.670.51-0.04-0.84-0.61-0.56-0.63
0.550.060.360.260.45-0.15-0.44-0.330.44-0.170.950.720.070.19-0.060.33-0.33-0.040.580.830.19-0.540.490.410.0-0.74-0.49-0.46-0.5
0.03-0.30.32-0.360.32-0.490.07-0.24-0.5-0.070.22-0.20.470.330.230.080.360.12-0.270.290.19-0.030.230.450.18-0.280.250.330.16
0.140.120.31-0.68-0.830.560.670.79-0.280.69-0.6-0.52-0.180.140.270.21-0.170.550.01-0.66-0.54-0.03-0.45-0.720.360.620.880.870.9
0.140.320.120.150.65-0.26-0.48-0.550.05-0.290.540.290.320.09-0.12-0.260.3-0.010.10.670.490.23-0.450.27-0.01-0.67-0.43-0.4-0.43
-0.31-0.51-0.310.520.78-0.78-0.6-0.78-0.07-0.720.490.370.30.19-0.09-0.090.48-0.39-0.430.510.410.45-0.720.270.02-0.57-0.5-0.48-0.47
0.26-0.10.22-0.27-0.180.090.140.220.120.260.050.20.180.260.250.40.210.52-0.13-0.040.00.180.36-0.010.02-0.160.580.550.61
-0.30.1-0.17-0.25-0.750.340.560.64-0.310.26-0.77-0.59-0.40.040.02-0.12-0.220.07-0.2-0.84-0.74-0.280.62-0.67-0.57-0.160.480.440.5
0.14-0.020.35-0.76-0.710.370.690.71-0.350.63-0.54-0.480.030.260.370.22-0.030.52-0.13-0.61-0.490.250.88-0.43-0.50.580.480.990.94
0.16-0.040.39-0.79-0.680.340.70.68-0.390.64-0.5-0.50.050.260.370.24-0.030.54-0.12-0.56-0.460.330.87-0.4-0.480.550.440.990.93
0.06-0.160.29-0.69-0.740.290.540.73-0.410.5-0.55-0.5-0.190.260.20.220.030.68-0.19-0.63-0.50.160.9-0.43-0.470.610.50.940.93
Click cells to compare fundamentals
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Competition

In accordance with the recently published financial statements, Icad Inc has a Current Valuation of 22.98 M. This is 99.84% lower than that of the Health Care Technology sector and 99.82% lower than that of the Health Care industry. The current valuation for all United States stocks is 99.86% higher than that of the company.

Icad Current Valuation Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Icad's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Icad could also be used in its relative valuation, which is a method of valuing Icad by comparing valuation metrics of similar companies.
Icad is currently under evaluation in current valuation category among related companies.

Icad Fundamentals

About Icad Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Icad Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Icad using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Icad Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
iCAD, Inc. provides image analysis, workflow solutions, and radiation therapy for the treatment of cancer in the United States. The company was formerly known as Howtek, Inc. and changed its name to iCAD, Inc. in June 2002. iCAD, Inc. was incorporated in 1984 and is headquartered in Nashua, New Hampshire. Icad operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 136 people.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Icad Inc is a strong investment it is important to analyze Icad's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Icad's future performance. For an informed investment choice regarding Icad Stock, refer to the following important reports:
Check out Icad Piotroski F Score and Icad Altman Z Score analysis.
Note that the Icad Inc information on this page should be used as a complementary analysis to other Icad's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.

Complementary Tools for Icad Stock analysis

When running Icad's price analysis, check to measure Icad's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Icad is operating at the current time. Most of Icad's value examination focuses on studying past and present price action to predict the probability of Icad's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Icad's price. Additionally, you may evaluate how the addition of Icad to your portfolios can decrease your overall portfolio volatility.
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
CEOs Directory
Screen CEOs from public companies around the world
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Is Icad's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Icad. If investors know Icad will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Icad listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.49)
Revenue Per Share
0.676
Quarterly Revenue Growth
(0.27)
Return On Assets
(0.10)
Return On Equity
(0.21)
The market value of Icad Inc is measured differently than its book value, which is the value of Icad that is recorded on the company's balance sheet. Investors also form their own opinion of Icad's value that differs from its market value or its book value, called intrinsic value, which is Icad's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Icad's market value can be influenced by many factors that don't directly affect Icad's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Icad's value and its price as these two are different measures arrived at by different means. Investors typically determine if Icad is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Icad's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.